Saladax Biomedical

Happy holidays from the folks at Saladax! We hope you have a wonderful and safe Christmas and New Year's!

@avrobio Congratulations, Saladax is looking forward to working with you.

Today we announced a collaboration with @Saladax on a new high-speed diagnostic assay designed to simplify and streamline therapeutic drug monitoring. See details in our press release: bit.ly/2W02jHt #genetherapy

We're excited to announce positive data demonstrating the performance of our MyCare Insite Clozapine Test was presented at @ECNPtweets & @theCINP's Annual Meetings. The study shows our #antipsychotics test is comparable to standard laboratory-based tests: saladax.com/studies-featur…

We're excited to announce our MyCare Insite Clozapine Test is now CE marked! This is the first point-of-care test to aid in the treatment & monitoring of patients with schizophrenia. Learn more: mycaretests.com/insite. #ECNP2019 Read full press release: businesswire.com/news/home/2019…

We've really enjoyed talking with folks at #ECNP2019 about our new MyCare Insite analyser and the recently announced Clozapine test CE marked for use on the device. You can learn more at mycaretests.com/insite. #Psychiatry #Antipsychotics @ECNPtweets #TDM #Clozapine

Our stellar sales team representing Saladax at #ECNP2019! It’s been a busy time here interacting with so many leaders within the world of Psychiatry. @ECNPtweets ⠀ Take a look at our exciting new analyser at mycaretests.com/insite.⠀ ⠀ #psychiatry #tdm #antipsychotics

BFTP Client @Saladax Develops First #CEMark Rapid POC Test to Aid #Psychiatrists in Treating #Schizophrenia #Psychosis - #MyCare™ in 6 minutes using a drop of blood. bit.ly/2m7A0Ym @PADCEDNews #BenFranklin4PA

We’ve been having a great time here at #ECNP2019 talking to folks about our exciting new analyser, the MyCare Insite, and the new Clozapine test just announced for it. Learn more about the MyCare Insite at mycaretests.com/insite #antipsychotics # #clozapine #tdm @ECNPtweets

We're excited to announce that our MyCare Insite Clozapine Test is now CE marked for use on our MyCare Insite device: businesswire.com/news/home/2019… This is the first and only rapid point-of-care test CE marked to aid in the treatment and monitoring of patients with schizophrenia.

Our MyCare Psychiatry line offers the only commercially available assays to measure the most widely prescribed antipsychotics. #TDM of #antipsychotic drugs is a powerful tool that tailors treatment to the specific needs of #patients. Learn more: MyCareTests.com/Psychiatry #2019AACC

Our time at #2019AACC is off to a fantastic start! A lot of activity at our booth #705. Come stop by and talk to our team about our new point of care device and our psychiatry assays! ⠀ ⠀ #TDM #Antipsychotics #Patients #Clinicians #BloodTesting #Psychiatry #Analyser

We're having a great time here at #2019AACC this week! We are sharing a booth with one of our partners, Eurolyser. There's a lot of activity and discussion around our point of care analyser, the MyCare Insite- in addition to our assays! #TDM #Psychiatry #Diagnostics #Oncology

Did you know that most current 5-FU treatment often leads to toxicity? Learn more from patient stories at mycaretests.com/5-FU. Every patient deserves treatment that fits, that's why we believe it's time to #PersonalizeChemo #Oncology #MyCare #PersonalizedMedicine #Patients

On #WorldMentalHealthDay Saladax is dedicated more than ever to pursue our efforts with #antipsychotics . You can learn more about our mission and our work within #psychiatry at mycaretests.com

Thank you to John Kane and Ralph Aquila for a great talk today! #ECNP2018

@Saladax has arrived in Barcelona for the 31st annual #ECNP2018 Congress! It’s beautiful here.

We’re landing over in Barcelona now for #ECNP2018! Really excited for the coming days meeting folks within the #psychiatry space, talking about everything #antipsychotics #adherence and #TDM.

Are you a #clinician interested in topics surrounding #nonadherence? If you're at #ECNP2018, you won't want to miss out on our symposium Sunday 9:00 - 10:00 AM #antipsychotics #FridayFeeling

The second part of our symposium this Sunday at #ECNP2018 @ECNPTweets will be presented by Dr. Ralph Aquila, MD “Innovative Strategies to Improve #Adherence with #Antipsychotics” Q&A to follow ❓🗨️